Sysmex Corporation (TYO: 6869)

Market Cap	1.91T
Revenue (ttm)	491.29B
Net Income (ttm)	53.46B
Shares Out	623.51M
EPS (ttm)	85.65
PE Ratio	35.73
Forward PE	30.90
Dividend	30.00 (0.97%)
Ex-Dividend Date	Mar 28, 2025

Volume	1,177,200
Open	3,117.00
Previous Close	3,114.00
Day's Range	3,092.00 - 3,139.00
52-Week Range	2,138.00 - 3,206.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2024

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers;...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1968
• Employees: 10,042
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 6869

Financial Performance

In 2023, Sysmex's revenue was 461.51 billion, an increase of 12.43% compared to the previous year's 410.50 billion. Earnings were 49.64 billion, an increase of 8.42%.